Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-19-014321

President and CEO gave up 21,371 shares (to pay taxes)

  • President and CEO acquired 61,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-09-17 Exercise or conversion : show line 1 in the form +61,800 146,331 D
2019-09-17 Shares withheld for taxes : show line 2 in the form −21,371 $1.00 $21,371 124,960 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-09-17 Exercise or conversion : show line 3 in the form Restricted Stock Units −61,800 185,400 D
Loading xslF345X03/ownership.xml…